Antimetastatic activity of the photodynamic agent hypericin in the dark
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference25 articles.
1. Anticancer drug targets: cell cycle and checkpoint control
2. Tyrosine kinase inhibitor imatinib (STIS71) as an anticancer agent for solid tumours
3. Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
4. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
5. Small molecule modulators of cyclin-dependent kinases for cancer therapy
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HyBryte™ use in early-stage cutaneous T-cell lymphoma;Frontiers in Drug Discovery;2023-11-27
2. Photodynamic Therapy of Breast Cancer in Animal Models and Their Potential Use in Clinical Trials—Role of the Photosensitizers: A Review;Frontiers in Bioscience-Landmark;2023-07-21
3. New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells;Biomedicine & Pharmacotherapy;2023-07
4. Evolutionary Aspects of Hypericin Productivity and Endogenous Phytohormone Pools Evidenced in Hypericum Species In Vitro Culture Model;Plants;2022-10-18
5. Hypericin, a potential new BH3 mimetic;Frontiers in Pharmacology;2022-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3